5 October
“MRD Diagnosis and Treatment in Tumors of Haematopoietic and Lymphoid Tissues”
October 5, 2022
Hilton Istanbul Bomonti – M2 Floor - Meeting Room 21
| 9.00 – 9.15 | Opening Ceremony George Janossy Robert Gale Nikolai Tupitsyn |
Chairmen: George Janossy Robert Gale Dieter Hoelzer Nikolai Tupitsyn |
| 9.15 – 9.35 | Should MRD be an endpoint of CLL therapy? | Robert Gale |
| 9.35 – 9.55 | How the evaluation of minimal residual disease may influence a clinical decision? | Jean-Francois Rossi |
| 9.55 – 10.15 | Modern possibilities of MRD eradication in oncohematology. Which acute leukemia may be treated immunologically w/o chemotherapy? | Dieter Hoelzer |
| 10.15 – 10.35 | Localized conditioning of pleural environment | Vera S. Donnenberg |
| 10.35 – 10.55 | General principles of MRD monitoring in AML | Alexandra Palladina |
| 10.55 – 11.10 | Coffee Break | |
| 11.10 – 11.30 | Prognostic significance of MRD in children B-All at post-induction period | Mary Shervashidze |
| 11.30 – 11.50 | Umbilical cord blood NK-cells | Kapitolina Melkova |
| 11.50 – 12.10 | Modern approaches to hematogeneous metastasis prevention and cancer immune prophylaxis | Nikolai Tupitsyn |
| 12.10 – 12.30 | Multiomic cytokine analysis in hemato-immunology | Vladimir Jurisic |
| 12.30 – 13.00 | General discussion |